|
1
|
Burns A and Iliffe S: Alzheimer's disease.
BMJ. 338:b1582009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Querfurth HW and LaFerla FM: Alzheimer's
disease. New Eng J Med. 362:329–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Todd S, Barr S, Roberts M and Passmore AP:
Survival in dementia and predictors of mortality: A review. Int J
Geriatr Psychiatry. 28:1109–1124. 2013.PubMed/NCBI
|
|
4
|
Ballard C, Gauthier S, Corbett A, Brayne
C, Aarsland D and Jones E: Alzheimer's disease. Lancet.
377:1019–1031. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thompson CA, Spilsbury K, Hall J, Birks Y,
Barnes C and Adamson J: Systematic review of information and
support interventions for caregivers of people with dementia. BMC
Geriatr. 7:182007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Forbes D, Thiessen EJ, Blake CM, Forbes SC
and Forbes S: Exercise programs for people with dementia. Cochrane
Database Syst Rev. 12:CD0064892013.PubMed/NCBI
|
|
7
|
Mendez MF: Early-onset Alzheimer's
disease: Nonamnestic subtypes and type 2 AD. Arch Med Res.
43:677–685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of Disease Study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Berchtold NC and Cotman CW: Evolution in
the conceptualization of dementia and Alzheimer's disease:
Greco-Roman period to the 1960s. Neurobiol Aging. 19:173–189. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bonin-Guillaume S, Zekry D, Giacobini E,
Gold G and Michel JP: The economical impact of dementia. Presse
Med. 34:35–41. 2005.In French. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meek PD, McKeithan K and Schumock GT:
Economic considerations in Alzheimer's disease. Pharmacotherapy.
18:68–73; discussion 79–82. 1998.PubMed/NCBI
|
|
12
|
Francis PT, Palmer AM, Snape M and Wilcock
GK: The cholinergic hypothesis of Alzheimer's disease: A review of
progress. J Neuro Neurosurg Psychiatry. 66:137–147. 1999.
View Article : Google Scholar
|
|
13
|
Houghton PJ, Ren YH and Howes MJ:
Acetylcholinesterase inhibitors from plants and fungi. Nat Prod
Rep. 23:181–199. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hardy J and Allsop D: Amyloid deposition
as the central event in the aetiology of Alzheimer's disease.
Trends Pharmacol Sci. 12:383–388. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mudher A and Lovestone S: Alzheimer's
disease-do tauists and baptists finally shake hands? Trends
Neurosci. 25:22–26. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Quinn DM: Acetylcholinesterase: Enzyme
structure, reaction dynamics, and virtual transition states. Chem
Rev. 87:955–979. 1987. View Article : Google Scholar
|
|
17
|
Taylor P and Radić Z: The cholinesterases:
From genes to proteins. Ann Rev Pharmacol Toxicol. 34:281–320.
1994. View Article : Google Scholar
|
|
18
|
Sussman JL, Harel M, Frolow F, Oefner C,
Goldman A, Toker L and Silman I: Atomic structure of
acetylcholinesterase from Torpedo californica: A prototypic
acetylcholine-binding protein. Science. 253:872–879. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Radić Z, Gibney G, Kawamoto S,
MacPhee-Quigley K, Bongiorno C and Taylor P: Expression of
recombinant acetylcholinesterase in a baculovirus system: Kinetic
properties of glutamate 199 mutants. Biochemistry. 31:9760–9767.
1992. View Article : Google Scholar
|
|
20
|
Whittaker VP: The contribution of drugs
and toxins to understanding of cholinergic function. Trends
Pharmacol Sci. 11:8–13. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Purves D, Augustine GJ, Fitzpatrick D,
Hall WC, LaMantia AS, McNamara JO and White LE: Neuroscience. 4th
edition. Sinauer Associates; Sunderland, MA: pp. 121–122. 2008
|
|
22
|
Pohanka M: Alpha7 nicotinic acetylcholine
receptor is a target in pharmacology and toxicology. Inter J Mol
Sci. 13:2219–2238. 2012. View Article : Google Scholar
|
|
23
|
Ellman GL, Courtney KD, Andres V Jr and
Feather-Stone RM: A new and rapid colorimetric determination of
acetylcholinesterase activity. Biochem Pharmacol. 7:88–95. 1961.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomsen R and Christensen MH: MolDock: A
new technique for high-accuracy molecular docking. J Med Chem.
49:3315–3321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Van Der Spoel D, Lindahl E, Hess B,
Groenhof G, Mark AE and Berendsen HJ: GROMACS: Fast, flexible, and
free. J Comput Chem. 26:1701–1718. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin HQ, Ho MT, Lau LS, Wong KK, Shaw PC
and Wan DC: Anti-acetylcholinesterase activities of traditional
Chinese medicine for treating Alzheimer's disease. Chem Biol
Interact. 175:352–354. 2008. View Article : Google Scholar : PubMed/NCBI
|
